What Is The Forecast Valuation Of The Pharmacovigilance And Drug Safety Software Market Projected To Reach $4.09 Billion By 2029?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
How Big Is The Pharmacovigilance And Drug Safety Software Market Today And What Is Its Future Size?
In recent times, the pharmacovigilance and drug safety software market has experienced swift growth. It is projected to elevate from $2.26 billion in 2024 to $2.53 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. The expansion in the previous years is predominantly due to the rising demand for pharmacovigilance and drug safety software.
In the upcoming years, the pharmacovigilance and drug safety software market is predicted to witness a robust expansion. It is anticipated to escalate to $4.09 billion by 2029, boasting a compound annual growth rate (CAGR) of 12.7%. The surge during the projected timeline is credited to the escalating instances of negative drug reactions and the worldwide spread of pharmacovigilance, amplified incidences of adverse drug responses, heightened intricacy in drug safety norms, augment in the development of novel drugs and treatments, increasing cases of adverse drug reactions (ADRs), and an increase in the frequency of drug side effects. Noteworthy trends during the forecast timeframe encompass automation and AI amalgamation, cloud-centric solutions, technological novelty, advancements in technology, and the growing digitalization in healthcare.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Drivers Are Accelerating Expansion Of The Pharmacovigilance And Drug Safety Software Market?
The pharmacovigilance and drug safety software market is predicted to experience growth due to the increasing demand for personalized medicine. Personalized or precision medicine is a healthcare approach that customizes decisions and treatments to an individual patient’s unique traits. The rising demand for this type of medicine can be attributed to several factors, including better treatment results, a focus on prevention and early detection, and cost-effectiveness. Pharmacovigilance and drug safety software play a crucial role in personalized medicine, enhancing the safety and effectiveness of treatments tailored to the individual through the inclusion of pharmacogenetics, real-time data analysis, post-marketing monitoring, and personalized medication information. They also address ethical considerations and support thorough risk management strategies. For instance, the Personalized Medicine Coalition, a non-profit organization based in the US, noted that in February 2024, the FDA had approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the 6 approved in 2022. This rising demand for personalized medicine is thus a driving force behind the growth of the pharmacovigilance and drug safety software market.
How Is The Pharmacovigilance And Drug Safety Software Market Segmented Across Key Categories?
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
What Key Trends Are Driving Growth In The Pharmacovigilance And Drug Safety Software Market?
Leading firms in the pharmacovigilance and drug safety software market are pioneering novel technologies like cloud-based data lake platforms to bolster patient safety, streamline the monitoring of adverse events, and increase regulatory compliance in clinical trials and medical device post-market surveillance. A cloud-based data lake platform is a versatile, centralised storage system designed to store, control, and examine large quantities of both structured and unstructured data. It enables immediate data access and accommodates sophisticated analytics as well as AI/ML workloads. Take, for example, Thermo Fisher Scientific Inc., an American biotechnology firm, which in December 2023 introduced CorEvidence, a ground-breaking proprietary cloud-based data lake platform devised to boost pharmacovigilance procedures within clinical research registries. The aim of this platform is to fine-tune case processing and safety data management, particularly for post-authorization safety studies.
Who Are The Major Stakeholders Operating In The Pharmacovigilance And Drug Safety Software Market?
Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies
Access The Complete Report Here:
How Do Regional Dynamics Influence The Pharmacovigilance And Drug Safety Software Market Performance?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
